A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL
- Resource Type
- Article
- Source
- In
Blood 20 October 2022 140(16):1790-1802 - Subject
Immunobiology and Immunotherapy Lymphoid Neoplasia - Language
- ISSN
- 0006-4971